2021
#18: Brincidofovir for the Treatment of Disseminated Human Adenovirus Infection in Pediatric Solid-organ Transplant Recipients
Londeree J, Garro R, Romero R, George R, Winterberg P, Liverman R, Serluco A, Shin S, Yildirim I. #18: Brincidofovir for the Treatment of Disseminated Human Adenovirus Infection in Pediatric Solid-organ Transplant Recipients. Journal Of The Pediatric Infectious Diseases Society 2021, 10: s3-s3. DOI: 10.1093/jpids/piaa170.008.Peer-Reviewed Original ResearchPediatric SOT patientsAcute kidney injuryHAdV infectionSolid organ transplantationSOT patientsSevere diseaseResolution of AKIPediatric solid organ transplant recipientsSolid organ transplant recipientsAntiviral treatment optionsInvestigational antiviral drugsPediatric transplant centersBaseline clinical characteristicsDays of therapyMainstay of treatmentResolution of symptomsSubset of patientsHuman adenovirus infectionHAdV viral loadsAdenovirus viremiaBaseline creatinineGraft involvementGraft lossHAdV viremiaReduced immunosuppression
2020
Pulmonary Infections in the Immunocompromised Host
Yildirim I, Gibson J, Danziger-Isakov L. Pulmonary Infections in the Immunocompromised Host. Respiratory Medicine 2020, 235-252. DOI: 10.1007/978-3-030-54924-4_20.Peer-Reviewed Original ResearchPulmonary infectionHematopoietic stem cell transplantationCurrent immune statusSolid organ transplantationStem cell transplantationPrimary immunodeficiency patientsImmunocompromised childrenCommon complicationImmune compromiseImmunocompromised hostPulmonary diseaseBronchoalveolar lavageImaging findingsClinical symptomsCell transplantationImmune statusImmunodeficiency patientsInvasive studiesOrgan transplantationHigh riskCommon pathogensPatientsInfectionExposure historyTransplantation